March 12, 2026
TOPLINE: Among patients with obstructive sleep apnea (OSA) undergoing major noncardiothoracic surgery, sleep apnea-specific hypoxic burden (SASHB) — a measure of OSA severity — was significantly […]
March 11, 2026
Patients aged 6 years and older with cystic fibrosis will be able to access the triple combination treatment vanzacaftor/tezacaftor/deutivacaftor on NHS Scotland after the Scottish Medicines […]
March 4, 2026
Immunoglobulin (Ig)G and IgE appeared in only 10% of samples tested for possible allergic bronchopulmonary aspergillosis, based on data from more than 500 individuals presented at […]
March 2, 2026
TOPLINE: Pregnant women with asthma who were exposed to wildfire smoke for 10 days or more or early in pregnancy were more likely to deliver infants […]
February 27, 2026
Older adults are likely more sensitive to the asthma-promoting impact of environmental estrogens than youth, based on new research presented at the American Academy of Allergy, […]
February 26, 2026
The MHRA has licensed brensocatib (Brinsupri, Insmed Netherlands B.V.) as the first targeted therapy specifically for non- cystic fibrosis bronchiectasis (NCFB), offering a new treatment option […]
February 25, 2026
Respiratory syncytial virus (RSV) strongly inhibited rhinovirus (RV) when present first, but the reverse order of infection did not offer any inhibition, based on new data […]
February 24, 2026
Respiratory syncytial virus (RSV) infection makes an impact on the epithelium that varies with age, promoting asthma in children and chronic obstructive pulmonary disease (COPD) in […]
February 23, 2026
Feb 23 (Reuters) – Gossamer Bio’s experimental treatment failed to significantly improve exercise capacity in patients with a rare lung condition in a late-stage study, knocking […]